UniProt ID | LYRIC_HUMAN | |
---|---|---|
UniProt AC | Q86UE4 | |
Protein Name | Protein LYRIC | |
Gene Name | MTDH | |
Organism | Homo sapiens (Human). | |
Sequence Length | 582 | |
Subcellular Localization |
Endoplasmic reticulum membrane Single-pass membrane protein. Nucleus membrane Single-pass membrane protein. Cell junction, tight junction. Nucleus, nucleolus. Cytoplasm, perinuclear region. In epithelial cells, recruited to tight junctions (TJ) dur |
|
Protein Description | Downregulates SLC1A2/EAAT2 promoter activity when expressed ectopically. Activates the nuclear factor kappa-B (NF-kappa-B) transcription factor. Promotes anchorage-independent growth of immortalized melanocytes and astrocytes which is a key component in tumor cell expansion. Promotes lung metastasis and also has an effect on bone and brain metastasis, possibly by enhancing the seeding of tumor cells to the target organ endothelium. Induces chemoresistance.. | |
Protein Sequence | MAARSWQDELAQQAEEGSARLREMLSVGLGFLRTELGLDLGLEPKRYPGWVILVGTGALGLLLLFLLGYGWAAACAGARKKRRSPPRKREEAAAVPAAAPDDLALLKNLRSEEQKKKNRKKLSEKPKPNGRTVEVAEGEAVRTPQSVTAKQPPEIDKKNEKSKKNKKKSKSDAKAVQNSSRHDGKEVDEGAWETKISHREKRQQRKRDKVLTDSGSLDSTIPGIENTITVTTEQLTTASFPVGSKKNKGDSHLNVQVSNFKSGKGDSTLQVSSGLNENLTVNGGGWNEKSVKLSSQISAGEEKWNSVSPASAGKRKTEPSAWSQDTGDANTNGKDWGRSWSDRSIFSGIGSTAEPVSQSTTSDYQWDVSRNQPYIDDEWSGLNGLSSADPNSDWNAPAEEWGNWVDEERASLLKSQEPIPDDQKVSDDDKEKGEGALPTGKSKKKKKKKKKQGEDNSTAQDTEELEKEIREDLPVNTSKTRPKQEKAFSLKTISTSDPAEVLVKNSQPIKTLPPATSTEPSVILSKSDSDKSSSQVPPILQETDKSKSNTKQNSVPPSQTKSETSWESPKQIKKKKKARRET | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
45 | 2-Hydroxyisobutyrylation | LDLGLEPKRYPGWVI CCCCCCCCCCCCEEE | 56.01 | - | |
84 | Phosphorylation | GARKKRRSPPRKREE HHHHHCCCCCCHHHH | 43.20 | 30576142 | |
88 | Ubiquitination | KRRSPPRKREEAAAV HCCCCCCHHHHHHCC | 70.68 | - | |
107 | Ubiquitination | PDDLALLKNLRSEEQ HHHHHHHHHHCCHHH | 55.58 | 21890473 | |
111 | Phosphorylation | ALLKNLRSEEQKKKN HHHHHHCCHHHHHHH | 48.96 | 25159151 | |
121 | Ubiquitination | QKKKNRKKLSEKPKP HHHHHHHHHCCCCCC | 54.75 | - | |
125 | Ubiquitination | NRKKLSEKPKPNGRT HHHHHCCCCCCCCCE | 55.77 | - | |
127 | Ubiquitination | KKLSEKPKPNGRTVE HHHCCCCCCCCCEEE | 63.28 | - | |
132 | Phosphorylation | KPKPNGRTVEVAEGE CCCCCCCEEEEEECC | 23.55 | 28176443 | |
143 | Phosphorylation | AEGEAVRTPQSVTAK EECCEEECCCCCCCC | 21.05 | 29255136 | |
146 | Phosphorylation | EAVRTPQSVTAKQPP CEEECCCCCCCCCCC | 23.73 | 30266825 | |
148 | Phosphorylation | VRTPQSVTAKQPPEI EECCCCCCCCCCCCC | 33.12 | 28176443 | |
150 | Ubiquitination | TPQSVTAKQPPEIDK CCCCCCCCCCCCCCC | 54.71 | 21890473 | |
170 | Acetylation | KKNKKKSKSDAKAVQ HHCHHCCHHHHHHHH | 62.32 | 7676495 | |
171 | Phosphorylation | KNKKKSKSDAKAVQN HCHHCCHHHHHHHHH | 50.30 | 24425749 | |
174 | 2-Hydroxyisobutyrylation | KKSKSDAKAVQNSSR HCCHHHHHHHHHHCC | 54.82 | - | |
174 | Acetylation | KKSKSDAKAVQNSSR HCCHHHHHHHHHHCC | 54.82 | 7676507 | |
174 | Ubiquitination | KKSKSDAKAVQNSSR HCCHHHHHHHHHHCC | 54.82 | 21890473 | |
179 | Phosphorylation | DAKAVQNSSRHDGKE HHHHHHHHCCCCCCC | 16.20 | 28450419 | |
180 | Phosphorylation | AKAVQNSSRHDGKEV HHHHHHHCCCCCCCC | 40.98 | 23927012 | |
185 | Acetylation | NSSRHDGKEVDEGAW HHCCCCCCCCCCCHH | 61.70 | 26051181 | |
185 | Ubiquitination | NSSRHDGKEVDEGAW HHCCCCCCCCCCCHH | 61.70 | 21890473 | |
194 | Phosphorylation | VDEGAWETKISHREK CCCCHHHHHCCHHHH | 23.99 | 23186163 | |
195 | 2-Hydroxyisobutyrylation | DEGAWETKISHREKR CCCHHHHHCCHHHHH | 30.60 | - | |
195 | Acetylation | DEGAWETKISHREKR CCCHHHHHCCHHHHH | 30.60 | 27452117 | |
195 | Ubiquitination | DEGAWETKISHREKR CCCHHHHHCCHHHHH | 30.60 | - | |
197 | Phosphorylation | GAWETKISHREKRQQ CHHHHHCCHHHHHHH | 20.32 | 23401153 | |
212 | Phosphorylation | RKRDKVLTDSGSLDS HHHHHCCCCCCCCCC | 30.98 | 23663014 | |
214 | Phosphorylation | RDKVLTDSGSLDSTI HHHCCCCCCCCCCCC | 25.66 | 30278072 | |
216 | Phosphorylation | KVLTDSGSLDSTIPG HCCCCCCCCCCCCCC | 32.71 | 30278072 | |
219 | Phosphorylation | TDSGSLDSTIPGIEN CCCCCCCCCCCCCCC | 33.26 | 23663014 | |
220 | Phosphorylation | DSGSLDSTIPGIENT CCCCCCCCCCCCCCE | 30.75 | 23663014 | |
227 | Phosphorylation | TIPGIENTITVTTEQ CCCCCCCEEEEEHHH | 12.77 | 23663014 | |
229 | Phosphorylation | PGIENTITVTTEQLT CCCCCEEEEEHHHEE | 15.12 | 23663014 | |
231 | Phosphorylation | IENTITVTTEQLTTA CCCEEEEEHHHEEEE | 18.90 | 23663014 | |
232 | Phosphorylation | ENTITVTTEQLTTAS CCEEEEEHHHEEEEE | 19.87 | 23663014 | |
236 | Phosphorylation | TVTTEQLTTASFPVG EEEHHHEEEEECCCC | 21.73 | 23663014 | |
237 | Phosphorylation | VTTEQLTTASFPVGS EEHHHEEEEECCCCC | 28.97 | 23663014 | |
239 | Phosphorylation | TEQLTTASFPVGSKK HHHEEEEECCCCCCC | 28.17 | 26434776 | |
244 | Phosphorylation | TASFPVGSKKNKGDS EEECCCCCCCCCCCC | 40.46 | 26434776 | |
246 | Malonylation | SFPVGSKKNKGDSHL ECCCCCCCCCCCCCE | 66.64 | 30639696 | |
248 | Malonylation | PVGSKKNKGDSHLNV CCCCCCCCCCCCEEE | 73.33 | 26320211 | |
248 | Ubiquitination | PVGSKKNKGDSHLNV CCCCCCCCCCCCEEE | 73.33 | - | |
251 | Phosphorylation | SKKNKGDSHLNVQVS CCCCCCCCCEEEEEE | 38.24 | 25159151 | |
258 | Phosphorylation | SHLNVQVSNFKSGKG CCEEEEEEECCCCCC | 21.32 | 25159151 | |
261 | Methylation | NVQVSNFKSGKGDST EEEEEECCCCCCCCE | 63.65 | - | |
262 | Phosphorylation | VQVSNFKSGKGDSTL EEEEECCCCCCCCEE | 41.41 | 27251275 | |
264 | Acetylation | VSNFKSGKGDSTLQV EEECCCCCCCCEEEE | 67.64 | - | |
264 | Methylation | VSNFKSGKGDSTLQV EEECCCCCCCCEEEE | 67.64 | 115972663 | |
267 | Phosphorylation | FKSGKGDSTLQVSSG CCCCCCCCEEEEECC | 39.42 | 27251275 | |
268 | Phosphorylation | KSGKGDSTLQVSSGL CCCCCCCEEEEECCC | 26.42 | 27251275 | |
272 | Phosphorylation | GDSTLQVSSGLNENL CCCEEEEECCCCCCE | 13.01 | - | |
273 | Phosphorylation | DSTLQVSSGLNENLT CCEEEEECCCCCCEE | 48.74 | - | |
280 | Phosphorylation | SGLNENLTVNGGGWN CCCCCCEEEECCCCC | 24.41 | - | |
289 | Ubiquitination | NGGGWNEKSVKLSSQ ECCCCCHHHEECCCC | 58.29 | - | |
292 | Ubiquitination | GWNEKSVKLSSQISA CCCHHHEECCCCCCC | 50.14 | - | |
294 | Phosphorylation | NEKSVKLSSQISAGE CHHHEECCCCCCCCH | 17.93 | 29255136 | |
295 | Phosphorylation | EKSVKLSSQISAGEE HHHEECCCCCCCCHH | 41.80 | 30266825 | |
298 | Phosphorylation | VKLSSQISAGEEKWN EECCCCCCCCHHHHC | 23.68 | 29255136 | |
303 | Acetylation | QISAGEEKWNSVSPA CCCCCHHHHCCCCHH | 47.58 | 26051181 | |
303 | Ubiquitination | QISAGEEKWNSVSPA CCCCCHHHHCCCCHH | 47.58 | - | |
306 | Phosphorylation | AGEEKWNSVSPASAG CCHHHHCCCCHHHCC | 23.90 | 30266825 | |
308 | Phosphorylation | EEKWNSVSPASAGKR HHHHCCCCHHHCCCC | 17.99 | 19664994 | |
311 | Phosphorylation | WNSVSPASAGKRKTE HCCCCHHHCCCCCCC | 40.72 | 22167270 | |
314 | 2-Hydroxyisobutyrylation | VSPASAGKRKTEPSA CCHHHCCCCCCCCCC | 50.90 | - | |
314 | Acetylation | VSPASAGKRKTEPSA CCHHHCCCCCCCCCC | 50.90 | 25953088 | |
314 | Methylation | VSPASAGKRKTEPSA CCHHHCCCCCCCCCC | 50.90 | 12430023 | |
314 | Ubiquitination | VSPASAGKRKTEPSA CCHHHCCCCCCCCCC | 50.90 | - | |
323 | Phosphorylation | KTEPSAWSQDTGDAN CCCCCCCCCCCCCCC | 20.21 | 25159151 | |
326 | Phosphorylation | PSAWSQDTGDANTNG CCCCCCCCCCCCCCC | 29.35 | 23186163 | |
331 | Phosphorylation | QDTGDANTNGKDWGR CCCCCCCCCCCCCCC | 47.25 | 30108239 | |
334 | Acetylation | GDANTNGKDWGRSWS CCCCCCCCCCCCCCC | 52.99 | 26051181 | |
334 | Ubiquitination | GDANTNGKDWGRSWS CCCCCCCCCCCCCCC | 52.99 | - | |
338 | Methylation | TNGKDWGRSWSDRSI CCCCCCCCCCCCCCC | 30.60 | 115482437 | |
339 | Phosphorylation | NGKDWGRSWSDRSIF CCCCCCCCCCCCCCC | 27.30 | 25159151 | |
341 | Phosphorylation | KDWGRSWSDRSIFSG CCCCCCCCCCCCCCC | 25.13 | 23898821 | |
344 | Phosphorylation | GRSWSDRSIFSGIGS CCCCCCCCCCCCCCC | 32.73 | 21082442 | |
347 | Phosphorylation | WSDRSIFSGIGSTAE CCCCCCCCCCCCCCC | 28.03 | 28464451 | |
351 | Phosphorylation | SIFSGIGSTAEPVSQ CCCCCCCCCCCCCCC | 23.64 | 28450419 | |
352 | Phosphorylation | IFSGIGSTAEPVSQS CCCCCCCCCCCCCCC | 29.81 | 28464451 | |
357 | Phosphorylation | GSTAEPVSQSTTSDY CCCCCCCCCCCCCCC | 29.18 | 26552605 | |
359 | Phosphorylation | TAEPVSQSTTSDYQW CCCCCCCCCCCCCCE | 26.58 | 27251275 | |
360 | Phosphorylation | AEPVSQSTTSDYQWD CCCCCCCCCCCCCEE | 23.76 | 27251275 | |
361 | Phosphorylation | EPVSQSTTSDYQWDV CCCCCCCCCCCCEEC | 25.50 | 29978859 | |
362 | Phosphorylation | PVSQSTTSDYQWDVS CCCCCCCCCCCEECC | 34.12 | 29978859 | |
364 | Phosphorylation | SQSTTSDYQWDVSRN CCCCCCCCCEECCCC | 15.98 | 28796482 | |
369 | Phosphorylation | SDYQWDVSRNQPYID CCCCEECCCCCCCCC | 24.04 | 29978859 | |
411 | Phosphorylation | WVDEERASLLKSQEP CCCHHHHHHHHCCCC | 40.22 | 28258704 | |
415 | Phosphorylation | ERASLLKSQEPIPDD HHHHHHHCCCCCCCC | 39.48 | 25159151 | |
426 | Phosphorylation | IPDDQKVSDDDKEKG CCCCCCCCCCCCCCC | 42.21 | 29255136 | |
439 | Phosphorylation | KGEGALPTGKSKKKK CCCCCCCCCCCCHHH | 59.08 | 24732914 | |
441 | Acetylation | EGALPTGKSKKKKKK CCCCCCCCCCHHHHH | 62.67 | 30585989 | |
451 | Ubiquitination | KKKKKKKKQGEDNST HHHHHCCCCCCCCCC | 72.86 | - | |
457 | Phosphorylation | KKQGEDNSTAQDTEE CCCCCCCCCHHCHHH | 37.12 | 28355574 | |
458 | Phosphorylation | KQGEDNSTAQDTEEL CCCCCCCCHHCHHHH | 34.29 | 29255136 | |
462 | Phosphorylation | DNSTAQDTEELEKEI CCCCHHCHHHHHHHH | 21.19 | 30108239 | |
477 | Phosphorylation | REDLPVNTSKTRPKQ HHHCCCCCCCCCCCC | 31.66 | 29255136 | |
478 | Phosphorylation | EDLPVNTSKTRPKQE HHCCCCCCCCCCCCH | 27.16 | 29255136 | |
479 | Acetylation | DLPVNTSKTRPKQEK HCCCCCCCCCCCCHH | 46.65 | 25953088 | |
489 | Phosphorylation | PKQEKAFSLKTISTS CCCHHCEECEEECCC | 33.54 | 24719451 | |
491 | Acetylation | QEKAFSLKTISTSDP CHHCEECEEECCCCH | 42.48 | 25953088 | |
491 | Methylation | QEKAFSLKTISTSDP CHHCEECEEECCCCH | 42.48 | 24659541 | |
491 | Ubiquitination | QEKAFSLKTISTSDP CHHCEECEEECCCCH | 42.48 | 21890473 | |
492 | Phosphorylation | EKAFSLKTISTSDPA HHCEECEEECCCCHH | 26.00 | 30266825 | |
494 | Phosphorylation | AFSLKTISTSDPAEV CEECEEECCCCHHHH | 27.39 | 23401153 | |
495 | Phosphorylation | FSLKTISTSDPAEVL EECEEECCCCHHHHE | 33.04 | 30266825 | |
496 | O-linked_Glycosylation | SLKTISTSDPAEVLV ECEEECCCCHHHHEE | 34.50 | 31373491 | |
496 | Phosphorylation | SLKTISTSDPAEVLV ECEEECCCCHHHHEE | 34.50 | 30266825 | |
506 | Phosphorylation | AEVLVKNSQPIKTLP HHHEEECCCCCCCCC | 31.45 | 29214152 | |
510 | Ubiquitination | VKNSQPIKTLPPATS EECCCCCCCCCCCCC | 51.17 | - | |
511 | Phosphorylation | KNSQPIKTLPPATST ECCCCCCCCCCCCCC | 45.26 | 28555341 | |
516 | O-linked_Glycosylation | IKTLPPATSTEPSVI CCCCCCCCCCCCEEE | 41.79 | 31373491 | |
517 | Phosphorylation | KTLPPATSTEPSVIL CCCCCCCCCCCEEEE | 32.64 | 22468782 | |
518 | Phosphorylation | TLPPATSTEPSVILS CCCCCCCCCCEEEEE | 47.78 | 22468782 | |
521 | Phosphorylation | PATSTEPSVILSKSD CCCCCCCEEEEECCC | 18.63 | 28555341 | |
525 | Phosphorylation | TEPSVILSKSDSDKS CCCEEEEECCCCCCC | 20.99 | 28348404 | |
527 | Phosphorylation | PSVILSKSDSDKSSS CEEEEECCCCCCCCC | 38.68 | 30266825 | |
529 | Phosphorylation | VILSKSDSDKSSSQV EEEECCCCCCCCCCC | 54.77 | 26657352 | |
532 | Phosphorylation | SKSDSDKSSSQVPPI ECCCCCCCCCCCCCH | 39.97 | 23663014 | |
533 | Phosphorylation | KSDSDKSSSQVPPIL CCCCCCCCCCCCCHH | 30.45 | 23663014 | |
534 | Phosphorylation | SDSDKSSSQVPPILQ CCCCCCCCCCCCHHH | 42.14 | 23663014 | |
543 | Phosphorylation | VPPILQETDKSKSNT CCCHHHHCCCCCCCC | 35.45 | 23312004 | |
546 | Phosphorylation | ILQETDKSKSNTKQN HHHHCCCCCCCCCCC | 44.09 | 21712546 | |
548 | Phosphorylation | QETDKSKSNTKQNSV HHCCCCCCCCCCCCC | 57.74 | 21712546 | |
550 | Phosphorylation | TDKSKSNTKQNSVPP CCCCCCCCCCCCCCH | 40.89 | 21712546 | |
558 | Phosphorylation | KQNSVPPSQTKSETS CCCCCCHHHCCCCCC | 44.40 | - | |
560 | Phosphorylation | NSVPPSQTKSETSWE CCCCHHHCCCCCCCC | 40.66 | - | |
562 | Phosphorylation | VPPSQTKSETSWESP CCHHHCCCCCCCCCH | 49.87 | 23927012 | |
564 | Phosphorylation | PSQTKSETSWESPKQ HHHCCCCCCCCCHHH | 46.35 | 23927012 | |
565 | Phosphorylation | SQTKSETSWESPKQI HHCCCCCCCCCHHHH | 25.46 | 23927012 | |
568 | Phosphorylation | KSETSWESPKQIKKK CCCCCCCCHHHHHHH | 31.01 | 22167270 | |
570 | Ubiquitination | ETSWESPKQIKKKKK CCCCCCHHHHHHHHH | 74.14 | - | |
582 | Phosphorylation | KKKARRET------- HHHHHHCC------- | 41.94 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of LYRIC_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of LYRIC_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of LYRIC_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
ZBT16_HUMAN | ZBTB16 | physical | 19648967 | |
PLEC_HUMAN | PLEC | physical | 22939629 | |
CBP_HUMAN | CREBBP | physical | 18316612 | |
TOPRS_HUMAN | TOPORS | physical | 24529480 | |
CBP_HUMAN | CREBBP | physical | 26141861 | |
SND1_HUMAN | SND1 | physical | 28514442 | |
ZY11B_HUMAN | ZYG11B | physical | 28514442 | |
JUN_HUMAN | JUN | physical | 27956703 | |
EP300_HUMAN | EP300 | physical | 27956703 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-298; SER-344 ANDSER-369, AND MASS SPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-298; SER-308 ANDSER-426, AND MASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-143; SER-298; SER-308;SER-311; SER-426; THR-458 AND SER-568, AND MASS SPECTROMETRY. | |
"Phosphoproteome of resting human platelets."; Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,Schuetz C., Walter U., Gambaryan S., Sickmann A.; J. Proteome Res. 7:526-534(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-298 AND SER-426, ANDMASS SPECTROMETRY. | |
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry."; Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.; Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-426, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-111; SER-298; SER-308;SER-311; SER-415 AND SER-426, AND MASS SPECTROMETRY. |